Macrocycles in Drug Discovery
Recent Advances in Macrocyclic Hsp90 Inhibitors
Designed Macrocyclic Kinase Inhibitors
Anti-Inflammatory Macrolides to Manage Chronic Neutrophilic Inflammation
Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets
Macrocyclic Inhibitors of GPCR's, Integrins and Protein–Protein Interactions
α-Helical Peptide Drug Discovery
Optimizing the Permeability and Oral Bioavailability of Macrocycles
- Print publication date
- 16 Oct 2014
- Copyright year
- Print ISBN
- PDF eISBN
- ePub eISBN
About this book
This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.